These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 10694620)

  • 1. Novacor left ventricular assist system versus Heartmate vented electric left ventricular assist system as a long-term mechanical circulatory support device in bridging patients: a prospective study.
    El-Banayosy A; Arusoglu L; Kizner L; Tenderich G; Minami K; Inoue K; Körfer R
    J Thorac Cardiovasc Surg; 2000 Mar; 119(3):581-7. PubMed ID: 10694620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
    McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor, and HeartMate for bridging to heart transplantation.
    Minami K; El-Banayosy A; Sezai A; Arusoglu L; Sarnowsky P; Fey O; Koerfer R
    Artif Organs; 2000 Jun; 24(6):421-6. PubMed ID: 10886058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the type of ventricular assisted device influence survival, infection, and rejection rates following heart transplantation?
    Shuhaiber J; Hur K; Gibbons R
    J Card Surg; 2009; 24(3):250-5. PubMed ID: 19438776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Success rates of long-term circulatory assist devices used currently for bridge to heart transplantation.
    Arabia FA; Smith RG; Rose DS; Arzouman DA; Sethi GK; Copeland JG
    ASAIO J; 1996; 42(5):M542-6. PubMed ID: 8944938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology.
    McCarthy PM; Smedira NO; Vargo RL; Goormastic M; Hobbs RE; Starling RC; Young JB
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):904-12. PubMed ID: 9576228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device and patient management in a bridge-to-transplant setting.
    El-Banayosy A; Körfer R; Arusoglu L; Kizner L; Morshuis M; Milting H; Tenderich G; Fey O; Minami K
    Ann Thorac Surg; 2001 Mar; 71(3 Suppl):S98-102; discussion S114-5. PubMed ID: 11265874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with the Novacor left ventricular assist system as a bridge to cardiac transplantation, including the new wearable system.
    Vetter HO; Kaulbach HG; Schmitz C; Forst A; Uberfuhr P; Kreuzer E; Pfeiffer M; Brenner P; Dewald O; Reichart B
    J Thorac Cardiovasc Surg; 1995 Jan; 109(1):74-80. PubMed ID: 7815810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution.
    Kalya AV; Tector AJ; Crouch JD; Downey FX; McDonald ML; Anderson AJ; Bartoszewski CJ; Hosenpud JD
    J Heart Lung Transplant; 2005 Nov; 24(11):1973-5. PubMed ID: 16297807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic left ventricular support with a vented electric assist device.
    Frazier OH
    Ann Thorac Surg; 1993 Jan; 55(1):273-5. PubMed ID: 8417699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation.
    Frazier OH; Rose EA; Oz MC; Dembitsky W; McCarthy P; Radovancevic B; Poirier VL; Dasse KA;
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1186-95. PubMed ID: 11726895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation?
    Navia JL; McCarthy PM; Hoercher KJ; Feng J; Jeevantham R; Smedira NG; Banbury MK; Blackstone EH
    Ann Thorac Surg; 2002 Dec; 74(6):2051-62; discussion 2062-3. PubMed ID: 12643395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement.
    Loebe M; Hennig E; Müller J; Spiegelsberger S; Weng Y; Hetzer R
    Eur J Cardiothorac Surg; 1997 Apr; 11 Suppl():S18-24. PubMed ID: 9271176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemodynamic and physiologic changes during support with an implantable left ventricular assist device.
    McCarthy PM; Savage RM; Fraser CD; Vargo R; James KB; Goormastic M; Hobbs RE
    J Thorac Cardiovasc Surg; 1995 Mar; 109(3):409-17; discussion 417-8. PubMed ID: 7877301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA sensitization in ventricular assist device recipients: does type of device make a difference?
    Kumpati GS; Cook DJ; Blackstone EH; Rajeswaran J; Abdo AS; Young JB; Starling RC; Smedira NG; McCarthy PM
    J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1800-7. PubMed ID: 15173739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience.
    Morgan JA; John R; Rao V; Weinberg AD; Lee BJ; Mazzeo PA; Flannery MR; Chen JM; Oz MC; Naka Y
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1309-16. PubMed ID: 15115987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
    Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.